Corticosterone was the first biologically active hormone to be isolated from adrenal gland extracts (1, 2). Although contributing little to the body pool of adrenocortical steroids in man, it is one of the major adrenocortical secretory products in some animals, e.g., rodents (3) . In man the major glucocorticosteroid is cortisol and the major mineralocorticosteroid is probably aldosterone; nevertheless, corticosterone has been identified and measured in human adrenal tissue (4), adrenal gland perfusates (5) , adrenal vein blood (6) (7) (8) , and peripheral blood (9) (10) (11) (12) (13) (14) (15) (16) . In all of these tissues the corticosterone concentration was found to be lower than that of cortisol, although the concentration of the biologically important aldosterone has been found to be even less than that of the corticosterone (17, 18) .
Unlike cortisol, little is known about the rates of secretion of corticosterone in the normal subject, or its alteration in disease. This paucity of knowledge stems largely from the fact that there are no readily available quantitative or semiquantitative methods for determining even a single fraction of the metabolites of corticosterone in the urine.
In previous reports we have described studies on the physiological disposition and metabolic fate of cortisol (19) and cortisone (20) in man. This paper describes similar studies with corticosterone using corticosterone, corticosterone-4-C14, and H3-labeled corticosterone. Seventeen normal subj ects, one bilaterally adrenalectomized subject, and patients with cirrhosis, myxedema, and thyrotoxicosis were studied.
Corticosterone was prepared for intravenous administration by dissolving 50, 100 or 200 mg of the crystalline steroid in 10 to 15 ml ethanol, which was added to 300 ml sterile 5 per cent dextrose in water. The solution was infused over a period of 10 to 20 minutes. The orally administered corticosterone was suspended in saline or given in a gelatin capsule. Corticosterone-4-C"4 (0.004 ,uc per ,g) was administered intravenously in trace quantities (100 to 400 ,ug) in a small volume of 5 per cent ethanol in sterile distilled water over a period of 5 minutes. Corticosterone-HW (1.5 utc per lAg) was administered in trace quantities (7 to 30 ,ug) in a small volume of 5 per cent ethanol in sterile distilled water. After injection of the steroids, heparinized blood samples were collected at 20 to 30 minute intervals.
The extraction procedures for the plasma corticosterone were similar to those described previously for cortisol (19) . Following the infusion of the pharmacalogical quantities of the steroid, two different methods were used to determine the plasma corticosterone concentration.
Fluorometric assay. Five-tenths ml plasma was extracted with 5 ml dichloromethane [purified by passage through a column of silica gel (21) ]. The plasma was removed by aspiration, and the dichloromethane extract 21-trihydroxy-1,4-pregnene-3,20-dione) ; 11-dehydrotetrahydrocorticosterone (3a,21-dihydroxy-pregnane-11,20-dione); 3a-allotetrahydrocorticosterone (3a,1 1p,21-trihydroxy-allopregnane-20-one); 11-dehydroallotetrahydrocorticosterone (3a,21 -dihydroxy-allopregnane-11,20 -dione); 11-dehydro-corticosterone (21-hydroxy-4-pregnene- washed with 0.5 ml 0.1 N NaOH. Each of two 2 ml aliquots of the extract was transferred to a small conical test tube and shaken with 1 ml of a sulfuric acid-ethanol (redistilled ethanol) reagent (65: 35 vol/vol). The solvent was removed by aspiration and the acid-alcohol reagent transferred to a small cuvet for fluorescence determination in a Farrand fluorometer by a previously described modification (12) of the method of Sweat (22) . Isotope dilution assay. The plasma samples were also assayed for corticosterone by the isotope dilution procedure as previously described (12) , except that 5 ml of plasma was used for each determination. Radioactivity measurements were made in a Tri-Carb liquid scintillation spectrometer (Packard Instrument Co.). Determination of plasma corticosterone-H' and labeled imetabolites. The disappearance of HW-labeled corticosterone from the plasma was determined by first adding a known number of counts of corticosterone-4-C" (500 cpm at an efficiency of 30 per cent) to a known volume of each plasma sample collected after the infusion of the labeled steroid. The plasma was extracted with dichloromethane and the residue chromatographed in a modified Bush-type system (23) (cyclohexane 100: benzene 100: methanol 100: water 50) for 24 hours at room temperature using unlabeled corticosterone (20 ,sg) as a marker. The corticosterone was then located with ultraviolet light, eluted, and assayed for C" and H' in a liquid scintillation spectrometer. The C" in this case was used to correct for losses of corticosterone-H' during the extraction, evaporation, chromatography, and elution steps. The mixtures of C" and H' were counted by previously described methods (24) . The combined plasma "free" corticosterone and its metabolites were measured by direct counts of an aliquot of the dichloromethane extract of the plasma. The plasma radioactive metabolites of corticosterone conjugated with glucuronic acid were determined by a previously described method (19) .
Determination of specific activity of labeled plasma corticosterone. Fifteen to 20 ml of heparinized plasma collected serially after injection of corticosterone-H' was extracted with 7 volumes of dichloromethane. The plasma was removed by aspiration, and the dichloromethane washed successively with 1/10 volume 0.1 N NaOH and 1/10 volume of 0.1 M acetic acid. The dichloromethane extract was evaporated to dryness.
Twenty gg of 11-desoxycortisol was added to the residue, and this was applied to Whatman no. 1 filter paper and chromatographed (cyclohexane 100: benzene 100: methanol 100: water 50) for 24 hours. After the chromatography the strip was scanned with ultraviolet light, and the 11-desoxycortisol located. (Corticosterone in 24 hours runs 2 to 3 cm slower than 11-desoxycortisol in this system.) The 3 to 4 cm portion of the paper just proximal to 11-desoxycortisol was cut out and the corticosterone eluted with ethanol. The alcohol was evaporated to dryness in a small, conical, glass-stoppered test tube.
The dry residue was acetylated with equal parts of 15 per cent (vol/vol) acetic anhydride-1-C" (2 mc per mmole) in benzene and in pyridine for 24 hours at room temperature. The unused acetic anhydride was removed by partitioning twice between a small volume of 20 per cent ethanol and dichloromethane. The aqueous layer was removed by aspiration into an alkali trap. After addition of 20 /Ag of corticosterone acetate, the dichloromethane was evaporated to dryness. The residue was chromatographed successively in the following systems: 1) cyclohexane 100: benzene 50: methanol 100: water 25, 15 hours; 2) cyclohexane 100: dioxane 100: methanol 50: water 25, 18 hours; and 3) cyclohexane 100: benzene 50: methanol 100: water 25, 15 hours. After elution from the second chromatographic purification and prior to the third and final chromatography, the residue was oxidized to 11-dehydrocorticosterone acetate with 0.1 ml 0.5 per cent CrO3 in redistilled glacial acetic acid. After exposure to the CrO3 for 1 minute at room temperature, 1 ml of 20 per cent ethanol-water was added and the steroid acetate was extracted with dichloromethane. The dichloromethane was evaporated to dryness and the residue applied to paper for the third chromatographic purification.
The 11-dehydrocorticosterone acetate was eluted into a counting vial, dried, and 5 ml toluene containing 0.4 per cent DPO (diphenyloxazole) and 0.004 per cent POPOP [1,4-bis-2-(5-phenyloxazolyl) -benzene] phosphor added. The samples were assayed for C" and H' in a liquid scintillation spectrometer. The calculations of the specific activities have been described previously (24) . From a knowledge of the specific activity of the acetic anhydride-1-C" and the C" counts in the counting vial, it was possible to determine the micrograms of corticosterone in the vial. From the counts of tritium and the micrograms of corticosterone in the vill, the specific activity of the corticosterone was determined. The fractional rate of turnover of corticosterone and the miscible pool size were determined as previously described for cortisol (25) .
Comparison of in vivo metabolism of H'-and C"-labeled corticosterone. A solution of 320 ,ug corticosterone labeled with both H' and C" was injected into a normal subject (N. K.) who was receiving a continuous intravenous infusion of corticotropin (4 units per hour) for 36 hours. The labeled steroid was given 12 hours after the start of the infusion. Blood samples were collected every 30 minutes for 3 hours. The plasma corticosterone specific activities were determined as previously described (isotope dilution assay utilizing measurements of fluorescence), except that both radioactive carbon and tritium measurements were made. The ratio of specific activities of the carbon and tritium were constant for the 3 hours of the study, thus indicating that the C"-and H'-labeled corticosterone were probably handled in a similar manner (Figure 1 ). The C"-and H'-labeled urinary metabolites were also assayed in this same subject, and no significant differences were found in the rate of excretion of the administered C" and H' in the total, free, and glucuronide-con- (18) . Studies of the plasma fractions (total, free, and glucuronide) following the infusion of a mixture of H3-and C'4-labeled corticosterone also showed no differences in the H3 to C1' ratios (18) . Determinations were made of the C1' and H3 in the corticosterone, tetrahydrocorticosterone, allotetrahydrocorticosterone, and 11-dehydrotetrahydrocorticosterone isolated from the urine. The labeled corticosterone and 11-dehydrotetrahydrocorticosterone were diluted with their respective carrier steroids and recrystallized twice, and the C1' and H3 content again determined. It was not possible within the experimental error of the methods for counting the mixtures of H3 and C1' to observe any significant differences in the ratios of tritium to carbon in the urinary corticosterone or the metabolites of corticosterone. The ratio of H3 to C1' in all cases approximated the H3 to C1" ratio in the administered corticosterone.
Daily rate of turnover of corticosterone by assay of specific actizity of urinary metabolites. The specific activities of urinary corticosterone, tetrahydro-and allotetrahydrocorticosterone, and 1 1-dehydrocorticosterone were determined on the 24 hour collections of urine after the infusion of trace quantities of H3-labeled corticosterone (7 to 30 jsg), or slightly larger than trace quantities of corticosterone-4-C" (100 to 400 /Ag). The labeled corticosterone and its metabolites were presumed to be diluted only by the corresponding unlabeled steroid and its metabolites, and the collection of radioactivity in the metabolites was presumed to be nearly complete within the first 24 hours. From a knowledge of the specific activity of the isolated steroid and the quantity and specific activity of the injected steroid, plus a record of the time of the urine collection after administration of the labeled steroid, it was possible to calculate the rate of steroid secretion (17, 18, 26, 27) I i -1) a X no. days = micrograms of steroid secreted per day, where It = specific activity of :njected steroid; f = ratio molecular weight of injected steroid to molecular weight of steroid metabolite; L. = specific activity of diluted urinary steroid metabolite; a = micrograms of steroid injected.
The specific activities of urinary steroid metabolites were determined by the following method: one hundred to 200 ml of urine was treated with Sigma bacterial ,6-glucuronidase (50 units 10, 20 hours.
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Prior to the final chromatography, all of the derivatives were converted to the 11-oxo compounds by mild oxidation with CrO3. The diacetates of the 3a,5a (allo) compounds had a slower mobility than the 3a,5,8 isomers.2
The final purified steroid acetates were assayed for tritium and carbon radioactivity in a liquid scintillation spectrometer. From a knowledge of the specific activity of the labeled acetic anhydride plus the radioactive counts contributed to the final counting sample by the labeled acetoxy groups, it was possible to calculate the quantity of steroid in the counting vial. From the radioactive counts of the second (injected) steroid, plus the micrograms of steroid counted, it was possible to determine the specific activity of the urinary steroid metabolite after dilution by the endogenous steroid. As with all isotope dilution assays, the results were not invalidated by failure to obtain quantitative recoveries through any of the steps of the procedure.
Quantitatve determination of urinary inetabolites of corticosterone and cortisol. A known aliquot of the 24 hour urine was treated with Sigma bacterial 6-glucuronidase (100 units per ml urine, pH 6.2) for 24 hours at 370 C. The H3-labeled steroid tetrahydro metabolites 3 were added, and the urine extracted with dichloromethane. This extract was washed with alkali and acetic acid and evaporated to dryness. The residue was partially purified as previously described above. The residue used for the corticosterone metabolites was chromatographed in the cyclohexane 100: benzene 100: methanol 100: water 50 system for 24 hours. The free steroid metabolites were located as described above. The extracts for the cortisol metabolites were chromatographed in the benzene 100: methanol 50: water 25 system for 24 hours. The following steroid markers were used: cortisol, 32 cm; 3a-tetrahydrocortisol, 16 cm; A1-9a-fluorocortisol, 15 cm; 3a-allotetrahydrocortisol, 18 cm; 20,p-hydroxycortisone, 20 cm; 3a-tetrahydrocortisone, 27 cm; 9a-2 A more complete description of the chromatography systems will be described in a forthcoming publication. The monoacetate of corticosterone was chromatographed in the three solvent systems described above for determination of specific activity of labeled plasma corticosterone.
3 H3-labeled cortisol (1.0 ,uc per ,ug) and corticosterone (1.5 ,Ac per ,g) were prepared by exposure of 1.5 mg of the dry steroid acetates to H3 gas. The irradiated steroids were purified by paper chromatography (before and after hydrolysis of the acetates) to a constant specific activity. The 3a,5g tetrahydro H3 compounds were prepared enzymatically from the parent steroids with the soluble dehydrogenase enzymes from rat liver (28) , and the 3a,5a tetrahydro compounds were prepared from the parent H3 steroids with the particulate enzymes from the livers of thyrotoxic rats (29) . Twenty-five to 50 ml of normal urine was sufficient for the cortisol metabolites, whereas 100 to 200 ml was required for the assay of the corticosterone metabolites. Corticosterone-4-C4 (1.47 mc per mmole) was obtained from the Endocrine Study Section of the National Institutes of Health. With all steroids CrO3 oxidation preceded the third chromatography. After the final chromatography, the eluted steroids were assayed for C"4 and H3 in the liquid scintillation spectrometer, and the concentrations of urinary steroids were determined as previously described (24) .
Determination of labeled urinary mietabolites. The labeled urinary and biliary metabolites of corticosterone-4-C14 were measured by previously described methods (19, 20) , except that with the corticosterone-H3 and some of the corticosterone-4-C"4 studies the radioactive measurements were made with a liquid scintillation spectrometer. A small aliquot of urine (0.1 to 0.5 ml) was added directly to 10 ml toluene, phosphor, and enough ethanol to make the mixture miscible (2 to 6 ml). A correction for loss of efficiency due to "quenching" was made by utilizing a double isotope differential dilution technique (30) .
RESULTS
Rate of disappearance of corticosterone and "'corticosterone-like" material from the plasma after intravenous administration. When the serial concentrations of sulfuric acid-induced fluorescent material in the dichloromethane extracts of plasma after the infusion of corticosterone were plotted against time on semilogarithmic paper, a linear decline in plasma concentration was noted ( Figure  2 ). In some of the subjects this first order decline in plasma concentration did not begin until 30 to 60 minutes after the end of the infusion. The decline in plasma concentration during the 30 to 60 minutes after the end of the infusion was rapid and did not represent a single exponential. When corticosterone was assayed by the more selective isotope dilution method, the nonlinear nature of the initial concentration curve was also observed. With both the sulfuric acid-induced fluorescence and the isotope dilution assay the slopes of the slower linear curve of declining steroid concentrations were similar. However, in all instances the plasma levels of corticosterone as measured with the more specific isotope dilution assay were always 10 to 20 per cent lower than the levels obtained with the less selective fluorometric assay.
In one normal subject 0.4, 50, 100 and 200 mg corticosterone were infused on separate occasions (Figure 3 ). The slopes of the slower curve of declining steroid concentrations were similar at the three larger dosage levels. The similar rates for metabolism of these three different concentrations of corticosterone and the first order nature of the decline in plasma concentration indicated that the rate of metabolism of infused corticosterone was proportional to concentration. Also, corticosterone and its sulfuric acid-induced fluorescent metabolites were metabolized at a similar rate. These rates of metabolism were conveniently expressed as biological half-times. 4 shows the comparative rates of metabolism of corticosterone in normal subjects, in patients with cirrhosis, myxedema, and thyrotoxicosis, and in normal subjects treated with estrogens.
In the normal subjects the biological half-times ranged from 0.9 to 1.6 hours with a mean of 1.27 hours ± 0.3 SD. A more rapid rate of metabolism was observed in three patients with thyrotoxicosis. The patients with cirrhosis and myxedema showed only a slightly delayed capacity for metabolism of infused corticosterone. Normal subjects given estrogens also showed a delayed metabolism.
Disappearance of radioactive corticosterone from the plasma. Intravenously infused tracer quantities of H3-labeled corticosterone disappeared at a constant first order rate (Figures 3 and 5) . However, the rates of disappearance of the trace and the pharmacological quantities were different. The larger amounts were metabolized at a slower rate. This would not appear to be attributable to a difference in the rate of metabolism of the H3- 5 the plasma levels, in both studies on the same subject, represent a measure of the H3 label on the corticosterone. With the pharmacological dose, the plasma steroid concentrations were also measured by the fluorometric method and a halftime of 1.2 hours was found. The more rapid appearance in the plasma of the metabolites of corticosterone conjugated with glucuronic acid indicated that the trace dose disappeared from the plasma (metabolism) at a more rapid rate. As the corticosterone disappeared from the plasma, conjugated derivatives hydrolyzed with /8-glucuronidase appeared and reached a maximum at 30 to 60 minutes, at which time the free and conjugated fractions were of similar magnitude. Thereafter the conjugated fraction exceeded the free fraction. A large portion of the free and labeled steroids in the plasma following the injection of labeled corticosterone was not corticosterone. The labeled metabolites of corticosterone disappeared at a more rapid rate than corticosterone.
Excretion of corticosterone and its metabolites. Figure 6 shows the cumulative urinary and biliary excretion of labeled corticosterone following the intravenous administration of a tracer quantity of corticosterone-4-C'4 to a patient with a biliary cannula. The * THE = tetrahydrocortisone, THA = tetrahydro-11-dehydrocorticosterone, THF = tetrahydrocortisol, THB = tetrahydrocorticosterone, Allo-THE = allotetrahydrocortisone, Allo-THA = allotetrahydro-11-dehydrocorticosterone, Allo-THF = allotetrahydrocortisol, Allo-THB = allotetrahydrocorticosterone. t ACTH denotes continuous intravenous infusion of corticotropin (4 units/hr) for 36 hours. The assays were made on the urine collected from the twelfth to the thirty-sixth hour. $ Cortisol or corticosterone, 100 mg i.v. § P-S denotes urine corticoid assay (phenylhydrazine reacting chromogens after glucuronidase hydrolysis).
for comparison. Also, in these same subjects the rates of turnover of cortisol and corticosterone are listed.
Rate of turnover of corticosterone. After the injection of corticosterone-H3, serial determination of specific activity (counts per minute per microgram) of plasma corticosterone demonstrated a rapid initial fall in specific activity. Except for a brief period (0 to 20 minutes) following injection of the tracer, essentially linear relationships were secured when the isotope content of the plasma corticosterone was plotted against time on semilogarithmic coordinates. The decline in isotopic concentration at any time was proportional to the isotopic concentration at that moment (Figure 1) . From the intercepts of the plots, the specific activity of the corticosterone at the moment of mixing at time zero after injection was calculated. From this value and a knowledge of the quantity (7 to 30 jug) and specific activity (1.5 Mc per Mug) of the injected tracer, the magnitude of the miscible pool was calculated. In normal subjects the mean value for the miscible pool was 0.3 mg with a range of 0.20 to 0.40 mg (Table III) . In normal subjects studied during the 8 to 12 hours of a continuous 48 hour intravenous infusion of corticotropin the pool size ranged from 1.5 to 3.5 mg.
From the curve of declining isotopic concentration T1/2 was determined, and the slope of the curve, k, was calculated from the equation, k = log 2/T1/2. The quantity of corticosterone turned over per hour was calculated from the product of k and the pool size, and expressed as milligrams of corticosterone turned over per hour. The mean corticosterone turnover rate was 0.7 pool per hour, or 0.18 mg per hour, with a range of 0.14 to 0.34 mg per hour.
In the normal subjects given corticotropin the fractional turnover per hour was much the same as that in the normal subjects not given corticotropin; however, the pool size was increased nearly tenfold so that the rate of turnover of corticosterone was markedly increased. In the one subject in which a turnover rate study was carried out with a mixture of H3-and C14-labeled corticosterone, the results with each isotope were comparable. Serial When the fraction of corticosterone turned over per hour was extrapolated to daily turnover by multiplying by 24, the daily rates of turnover were calculated to be more than twice the values calculated from the turnover rate method utilizing the specific activity of one or more of the urinary metabolites of corticosterone, except for the subjects receiving corticotropin. With the latter method the daily rate of turnover was 1.5 to 4.0 mg with a mean of 2.3 mg (Table III) . There were no marked differences in the results using H3-and C14-labeled corticosterone. However, with the latter, larger amounts of steroid (200 to 300 pg) were injected. In the few instances in which allotetrahydrocorticosterone or 11-dehydrotetrahydrocorticosterone were isolated in addition to tetrahydrocorticosterone, there were no significant differences in the isotopic content. In some of these same subjects corticosterone was determined and its specific activity found to be 30 to 50 per cent higher than that found in the tetrahydro compounds. In the subjects receiving corticotropin, the calculated daily turnover rates by both methods were approximately the same.
As a means of evaluating the method utilizing specific activity measurements of urinary metabolites of the labeled steroid and also the stability of the H3 label, studies were carried out on a bilaterally adrenalectomized subject maintained on zXl-9a-fluorocortisol for the duration of the studies. The corticosterone-H3 isolated from the urine collected only during the eight hours following infusion had essentially the same specific activity as the injected steroid. Thirty ,ug of corticosterone-H3 plus 100 mg unlabeled corticosterone were infused into this same patient. In this study three of the tetrahydro metabolites were isolated from the 24 hour urine collection, and the calculated dilution of the administered labeled steroid closely approximated the expected value.
Absorption of corticosterone. Following the oral administration of corticosterone as the free alcohol, peak plasma corticosterone levels of 25 to 50,g per 100 ml were usually reached at one hour, and after six hours the plasma level had returned to the baseline control value. Figure 7 shows the results of one such study in a normal fasted subject. Data are also shown for the A wide range of pharmacological doses of infused corticosterone, like cortisol, disappeared rapidly from the plasma at a rate proportional to concentration. However, in the normal subjects corticosterone disappeared from the plasma at a slightly more rapid rate, with a biological halftime of 1.27 hours as compared to 1.83 hours for comparable doses of cortisol (19) . The use of the modification (12) of the selective sulfuric acid-induced fluorescence assay of Sweat (22) made the measurements of the corticosterone concentrations in the plasma after infusion of corticosterone relatively simple. Under the conditions of the study this assay proved to be relatively specific. Its validity was evaluated by the use of the more selective isotope dilution assay (12) , which usually yielded slightly lower plasma corticosterone levels and a slightly longer biological half-time for infused corticosterone. These differences probably indicated that some of the metabolites of corticosterone gave a moderate fluorescence and were metabolized more rapidly than corticosterone. The 20a and 20/3 reduced stereoisomers of corticosterone are known to be metabolites of corticosterone (31) , and with the fluorescence assay they yield approximately one-third the fluorescent intensity of corticosterone (12) .
In one normal subject given .50 mg of the 20,/ reduced metabolite of corticosterone, the infused steroid disappeared from the plasma (T1/2 = 0.9 hour as determined by the fluorescence assay) more rapidly than corticosterone (T1/2 = 1.3 hours).
One difference between the curves of plasma steroid concentrations of the cortisol and corticosterone was that in the case of the latter the curve in some instances did not become linear until 30 to 90 minutes after the midpoint of the infusion, whereas with the former or with cortisone the curve was usually linear within 20 to 30 minutes (19, 20) . This was true for both the fluorescence and the isotope dilution methods of assay, was characteristic of only a few individuals, and was not a function of the larger doses of administered corticosterone (50, 100 or 
mg).
This phenomenon was, however, shown to be dosedependent, because with the rapid infusion of trace doses of either H3-(7 to 30 jug) or C14-(200 to 400 jug) labeled corticosterone, the decline in concentration of labeled corticosterone was always linear within 20 minutes.
In addition to the variations, in the nature of the curve of plasma corticosterone after trace and pharmacological doses, it was also noted that the slopes of the linear portions of the concentration curves were different at the two dose levels. With the trace dose the slope was steeper and thus yielded a shorter biological half-time. This was not found to be due to an altered metabolism of the labeled steroid. With 100 rng of labeled corticosterone the fluorometric assay showed a slope or -1 similar to that obtained with the radioactive assay. In addition, the more rapid appearance and the higher plasma level of metabolites conjugated as glucuronides after the trace dose revealed another significant difference in the metabolism of corticosterone at different dose levels. Finally, determinations of the "apparent volume of distribution" of the labeled corticosterone at these two dosage levels also demonstrated a significant difference in the distribution of the infused labeled steroid (trace dose, 12 to 40 L; pharmacological dose, 60 to 90 L).
Except for the disparity in the initial portion of the curve of the declining corticosterone concentration at the two dosage levels, these same differences were noted with trace and pharmacological doses of cortisol (18) . It seems likely that differences in the fraction of nonprotein-bound and protein-bound steroid at physiological (trace) and pharmacological levels may explain these discrepancies. On the basis of the recent reports on the binding of cortisol (32) (33) (34) (35) (36) and corticosterone (33) (34) (35) 37) to plasma proteins, it is evident that when a trace dose of the steroid is infused, close to 100 per cent of the circulating plasma steroid is protein-bound, whereas with pharmacological doses only 70 to 80 per cent is protein-bound. After the infusion of 20 to 200 mg of steroid, plasma steroid levels may range from 50 to 200 -g per 100 ml. Thus a larger fraction of nonprotein-bound steroid is available for diffusion into the extravascular space, and equilibration between plasma and the extravascular space may not be approximated rapidly. Under these circumstances the plasma concentration may not be expressed as a constant first order function but rather as a series of exponential terms in which the exponents are functions of the rate constants, for enzymatic transformation by the liver, diffusion into the extravascular space, and re-entry into the plasma. In the absence of significant excretion, even though the rate of decline in plasma concentration represents a first order process, the rate of disappearance of the steroid, especially after infusion of pharmacological quantities, may not always represent a reliable index of the rate of metabolism of endogenous steroid at physiological levels.
It has previously been reported that the chloroform-soluble radioactive metabolites of corticosterone-4-C14 injected in trace amounts disappeared more rapidly from the plasma than the radioactive metabolites of cortisol-4-C14 (17, 38) . Also, the peak of the radioactivity of the glucuronide fraction in the plasma reached a maximum more rapidly. In one normal subject, two of the metabolites of corticosterone (20,8-hydroxycorti- costerone and 11-dehydrotetrahydrocorticosterone) and the lla epimer of corticosterone were metabolized more rapidly than corticosterone.
(20,8-Hydroxycorticosterone and 1 la-hydroxycorticosterone were assayed by the fluorescence method, and 11-dehydrotetrahydrocorticosterone by the double isotope dilution derivative assay.) Patients with liver disease showed no marked impairment in their capacity to metabolize corticosterone, whereas cortisol metabolism was significantly impaired (18, 39, 40) . Patients with myxedema and thyrotoxicosis were shown to have an altered metabolism of cortisol (18, 41, 42) , and a similarly altered corticosterone metabolism. Normal subjects treated with estrogens showed a delayed disappearance of both cortisol and corticosterone from the plasma (43) . This has been related to alterations in concentration of the steroidbinding proteins after administration of estrogens (43, 44) .
The major route of excretion of labeled metabolites of corticosterone, like that of cortisol and cortisone, was via the urine. Seventy to 90 per cent of the administered dose could be accounted for in the urine within three days. The cumulative rate of excretion of the labeled steroid metabolites was also similar for these three steroids-TI/2= 2.5 to 4 hours. Only a small fraction of the metabolites of corticosterone was excreted into the gastrointestinal tract via the bile. Only 3 to 5 per cent of the administered steroid was excreted in the urine as radiometabolites directly extractable with dichloromethane, and less than 0.5 per cent of the administered corticosterone was recoverable as unaltered corticosterone. By paper chromatography the direct dichloromethane extracts of urines collected after infusions of 200 mg of corticosterone were found to contain trace amounts of the 20a and 20/8 hydroxy metabolites of corticosterone.4 These findings were based on a comparison of the rates of migration of the authentic pure compounds, and by conversion of the steroids to the diacetates and comparison of their chromatographic behavior with that of the authentic derivatives. These two substances isolated from the urine also gave negative reactions with the phenylhydrazine and alkaline blue tetrazolium reagents. Both compounds also gave the alkaline and sulfuric acid fluorescence reactions. Glucuronidase hydrolysis released radiometabolites equivalent to 40 to 60 per cent of the administered steroid. Incubation of the urine at room temperature for 24 hours at pH 1 did not release any radiometabolites. These results are in agreement with the previous data reported for cortisol (19, (45) (46) (47) , cortisone (20) , and corticosterone (17, 38, 48) .
Following the intravenous or oral administration of trace (200 ,ug) amounts of labeled corticosterone, comparable amounts of labeled metabolites were present in the urine within 24 hours. However, following the oral administration of 100 to 200 mg of the labeled steroid, a smaller fraction of the urinary metabolites appeared within 24 hours, and after feeding 100 mg of labeled corticosterone acetate, even less appeared in the 24 hour urine. These data are at variance with those on cortisol and cortisone, which indicated that after administration of the free alcohols of the steroids in trace or larger amounts the recovery of the radiometabolites in the urine was not appreciably altered (19, 20, 48) . With cortisone acetate the oral absorption of trace and large doses also gave similar results. With trace doses of cortisol, cortisone and corticosterone and with their acetates, oral and intravenous administration gave comparable results. However, when administered in pharmacological amounts, cortisol acetate and corticosterone acetate and, to a lesser extent, corticosterone were poorly absorbed from the gastrointestinal tract. This was substantiated by measurements of the concentrations of cortisol and corticosterone in the peripheral blood after oral administration of 100 to 200 mg of the acetates, and the free alcohols of these steroids. After the administration of the acetates, only minimal increases of the plasma steroid levels were observed. After oral corticosterone the plasma levels were less than one-third those observed after administration of comparable amounts of cortisol. These lower plasma levels are probably the result of a less efficient absorption and more rapid metabolism of the corticosterone.
By utilizing a double isotope derivative or double isotope dilution assay, some information has been obtained regarding the identity and the quantities of the metabolites of corticosterone comprising the free and conjugated (glucuronide) fractions of the urine. In the normal subject the major a-ketolic steroids released after glucuronidase hydrolysis consisted of the tetrahydro (3a) and allotetrahydro (3a) metabolites of corticosterone and 11-dehydrocorticosterone. Allotetrahydrocorticosterone was the major metabolite, and the tetrahydrocorticosterone concentration usually exceeded that of 11-dehydrotetrahydrocorticosterone. Other investigators have also reported that the concentration of allotetrahydrocorticosterone exceeds that of other a-ketol tetrahydro compounds, and that the level of tetrahydrocorticosterone usually exceeds that of the 11-dehydro metabolites (49) (50) (51) (52) . Pregnane-3a,11/,8, 20a-triol and 3a,1 1,8,dihydroxypregnane-20-one have also been isolated from the urine of patients treated with large amounts of corticosterone (53). 11-Dehydrocorticosterone has also been isolated from the urines of such patients (52) . Normally the predominant metabolite of cortisol is tetrahydrocortisone (3a), although tetrahydrocortisol (3a) and its 5a isomer, allotetrahydrocortisol (3a), appear in measurable quantities (54) .
To resolve some of the uncertainties associated with estimations of corticosterone production from determinations of the a-ketol tetrahydrometabolites, we have utilized labeled corticosterone to obtain a more quantitative measure of the rate of synthesis of corticosterone. The same two techniques employed for cortisol turnover rates (18, 25, 27) ( 17, 26, 56, 57) , including cholesterol (58), have been used for tracer studies in human beings and in animals, and there is evidence that the H3 label is sufficiently stable. We have previously published data on the metabolism of simultaneous intravenously administered mixtures of corticosterone-4-C"4 and randomly labeled corticosterone-H3 (18) . In these studies H3-labeled corticosterone and corticosterone-4-C4 did not appear to be metabolized differently. On the basis of the studies of Ayres and associates (17) it was indicated that H -labeled corticosterone (16-H3) was metabolized like the parent steroid.
In the normal subjects given rapid infusions of trace quantities (7 to 30 Mg) of corticosterone-H , the rapidly exchangeable pool of corticosterone ranged from 0.20 to 0.40 mg with a mean of 0.3 mg. In these same subjects the plasma concentration of corticosterone was 0.8 to 1.5 /Ag per 100 ml with a mean of 1.0 pg per 100 ml. From the mean plasma corticosterone concentration and the mean corticosterone pool size, it was possible to calculate on "apparent volume of distribution" of this pool. This was calculated to be 30 L. This volume, like that for cortisol (19, 25) , has no physical reality and must be regarded solely as that theoretical volume required to contain the rapidly exchangeable corticosterone at its concentration in plasma. Following the infusion of 100 mg of unlabeled steroid, a two-to threefold larger volume of distribution was obtained, and this probably results from the fact that a larger fraction of the infused steroid diffused more rapidly into the extravascular space.
Within 8 to 12 hours after the continuous-infusion of corticotropin, the miscible pool of corticosterone (and the plasma concentration) showed a four-to tenfold increase. This change in pool size exceeds that previously reported for cortisol after infusion of corticotropin (18, 25) .
In the normal subjects both before and after the infusion of corticotropin the half-times of the specific activity curves of plasma corticosterone were similar as were the fractional rates of turnover of the miscible pool. However, after corticotropin the hourly rate of turnover of corticosterone was increased four-to tenfold.
With the kinetic method, it was possible to measure the rate of synthesis of corticosterone over a period of only a few hours because the labeled steroid could not be obtained .with a sufficiently high specific activity so that a large enough quantity could be used to obtain a measurable yield of radioactivity and yet inject a trace quantity. Also, plasma corticosterone shows a diurnal variation similar to that of cortisol (13, 18) , and thus the pool would probably not remain sensibly constant for more than a few hours. Studies of cortisol turnover at different times of the day revealed a marked variation in the hourly turnover rate (18, 25) . By measuring the specific activity of one or more of the urinary radiometabolites of corticosterone, the daily rate of turnover of endogenous corticosterone was determined. With this method it was possible to use the lower specific activity corticosterone-4-C"4, since the 200 Mug injected represented a trace quantity when compared to the total daily production. Results with either corticosterone-4-C14 or corticosterone-H3 were in good agreement. The specific activities of tetrahydrocorticosterone, allotetrahydrocorticosterone and 1 1-dehydrotetrahydrocorticosterone were comparable, and thus it would appear that each of these metabolites arises solely from a common parent compound (corticosterone). With this technique rates of turnover of 1.3 to 4.0 mg per day were found for normal subjects. When the results of the kinetic method were expressed on the basis of the daily turnover, the data did not agree with the urine specific activity method, and in all instances the former method gave higher values. This undoubtedly indicates that the rate of turnover of corticosterone during the morning hours, at a time when the plasma level of corticosterone is highest (13) , is greater than it is at other times of the day. Inaccuracies in the determination of the pool size may also be responsible for appreciable errors in the kinetic assay. Since the corticosterone is metabolized rapidly, prompt dilution of the labeled steroid within the pool, prior to its metabolism, may not occur, and thus the pool size calculations represent only a first approximation. Also, other slower mixing pools may be present and undetected with this type of measurement.
In the studies with corticotropin the turnover rates by the kinetic method, when extrapolated to 24 hours, agreed reasonably well with the results obtained from the urine specific activity method.
In these instances, however, the miscible pool of corticosterone probably remained reasonably constant. In the bilaterally adrenalectomized subject, the specific activity of the labeled urinary tetrahydrocorticosterone was close to that of the injected labeled corticosterone, indicating no significantly measurable secretion of corticosterone, or other extra-adrenal products metabolized to the tetrahydro metabolites of corticosterone.
In the only other study of corticosterone secretion, Ayres and co-workers (17) reported a daily turnover of 0.84 mg in one normal subject. They measured the dilution of H3-labeled corticosterone by assaying the specific activity of the urinary corticosterone. In two of the subjects of this study the daily turnover rate was calculated by measuring the specific activity of the urinary corticosterone, and a lower secretion rate was found (one-third to one-half that obtained by assay of the tetrahydrometabolites). We also observed this discrepancy between the specific activities of the cortisol and the tetrahydro metabolites of cortisol in normal subjects (18) . Cope and Black (27) also observed this difference, i.e., a higher specific activity for the urinary cortisol. It seems probable that these differences may result from the fact that when the steroid is injected rapidly (three to five minutes), it is not well mixed with the body pool prior to excretion, and a larger amount is excreted initially as the free compound.
It is of interest that with both cortisol and corticosterone the fraction of the steroids excreted as the 3a tetrahydro and 3a allotetrahydro metabolites conjugated as glucuronides represented onethird to one-half of the total daily production of the steroids. This was also noted after administration of corticotropin or 100 mg of the steroids. Normally the tetrahydro metabolites of corticosterone are present in the urine in much lower concentrations than the tetrahydro metabolites of cortisol.
Peripheral plasma values of corticosterone have in many instances been reported to approximate or equal those for cortisol (59) . This suggested that adrenal corticosterone secretion approached that of cortisol. Bush has reviewed this information (60) and has suggested that the higher plasma corticosterone values previously reported probably resulted from inadequate purification of the steroid prior to analysis. The data on the relative amounts of cortisol to corticosterone in the miscible pool, in the peripheral blood (9) (10) (11) (12) (13) (14) (15) (16) , and in urine (13, 17) support the concept that corticosterone secretion is very much less than that of cortisol and the turnover rate studies confirm this.5 Other than the fact that corticosterone is metabolized slightly more rapidly than cortisol, the physiological disposition and metabolic fate of these two steroids are not greatly different.
SUMMARY
In normal subjects infused corticosterone was shown to disappear from the plasma more rapidly than cortisol. With the administration of large (therapeutic) doses of corticosterone, its rate of disappearance was found to be proportional to concentration. However, trace doses of labeled corticosterone disappeared from the plasma more rapidly than the larger doses. In patients with cirrhosis and myxedema the disappearance of corticosterone from the plasma was only slightly slower than normal, whereas in normal subjects treated with estrogens its disappearance was definitely delayed. In patients with thyrotoxicosis the steroid disappeared from the plasma very rapidly.
Normal subjects within 72 hours excreted 80 to 90 per cent of the administered hormone as urinary and biliary metabolites, as judged by urinary (70 to 80 per cent) and biliary (11 per cent) excretion of C14-or H3-labeled steroids. Approximately 3 per cent of the administered hormone was excreted unconjugated, and less than 0.5 per cent as unchanged corticosterone. Forty to 60 per cent of the administered dose was excreted as metabolites hydrolyzed with p-glucuronidase. This fraction consisted predominantly of the tetrahydro and allotetrahydro reduction products of corticosterone. Allotetrahydrocorticosterone was the major tetrahydro metabolite. When administered in pharmacological doses, corticosterone, and especially corticosterone acetate, were found to be poorly absorbed from the gastrointestinal tract.
Utilizing trace quantities of intravenously ad- 5 Human adrenocortical tissue has also been found to contain less corticosterone than cortisol (4, 61) . Adrenal cortical tissue slices on incubation produce less corticosterone than cortisol (61) . Also, human adrenal vein plasma contains one-fifth to one-tenth as much corticosterone as cortisol (61) . ministered corticosterone-H3, the miscible pool size of corticosterone was found to be 0.2 to 0.4 mg, and the fractional turnover of the pool 0.7 mg per hour. Calculations of the rate of turnover of endogenously synthesized corticosterone, by measurements of the dilution of the specific activity of the urinary tetrahydro metabolites of intravenously administered corticosterone-4-C14 or corticosterone-H3, indicated a daily rate of production of 1.5 to 4.0 mg. Corticotropin increased the rate of synthesis of corticosterone seven-to tenfold.
Although the physiological disposition and metabolic fate of cortisol and corticosterone were not greatly different, the quantity of corticosterone secreted by the adrenal was only one-fifth to onetenth that of cortisol. This results in a lower circulating plasma corticosterone level, and the excretion of a smaller quantity of the tetrahydro metabolites of corticosterone.
